
Article 1 
Health claims set out in the Annex to this Regulation may not be made on food on the  Great Britain  market.
Article 2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 21 October 2009.
For the Commission
Androulla VASSILIOU
Member of the Commission
ANNEX
Application — Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Elancyl Global Silhouette® Clinically tested as of 14 days. Your silhouette is apparently and globally redrawn, resculpted and refined at 28 days EFSA-Q-2008-285
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data LGG® MAX multispecies probiotic LGG® MAX helps to reduce gastro-intestinal discomfort EFSA-Q-2008-444